Advertisement bioMerieux Signs Agreement With Brainware - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

bioMerieux Signs Agreement With Brainware

To automate accounts payable by Brainware's Distiller solution

Brainware has reported that bioMerieux has selected the company’s Distiller solution to automate its accounts payable process. bioMerieux maintains a global presence across 150 countries and is required to process hundreds of thousands of invoices and credit notes per year.

The new solution will enable bioMerieux to harmonize accounts payable processes throughout the organization and spread best practices across countries, as well as to integrate this process with its SAP enterprise resource planning system, which will be rolled out in the next two years.

Under this multi-year agreement, the company will leverage Brainware’s intelligent data capture solution to automatically extract and validate complex header and line item data, intelligently route exceptions to approvers, and access real-time key performance indicators and business metrics pertaining to suppliers and related invoices.

Carl Mergele, chief executive officer at Brainware, said: Competition in the biotech and pharmaceutical markets has been fierce over the past few years, particularly with the trends toward consolidation.

The Brainware Distiller solution can help companies like bioMerieux to thrive during today’s economic climate by allowing them to find cash inside their financial operations. During the last two years, we have significantly expanded our presence in this industry, as some of the most cutting-edge companies have adopted our innovative solutions.